Bladder mesh, more accurately called surgical mesh for pelvic floor repair, is a synthetic implant placed through the vagina or abdomen to support weakened tissues in the pelvis. It is most commonly made of polypropylene, a lightweight plastic, and has been used to treat stress urinary incontinence and pelvic organ prolapse in women. While the device helped many patients, it also caused serious and sometimes permanent complications in a significant number of them, leading the FDA to order the last transvaginal prolapse mesh products off the U.S. market in 2019.
What Bladder Mesh Actually Is
The term “bladder mesh” is informal. In medical settings, these devices go by names like midurethral slings (for incontinence) and transvaginal mesh or sacrocolpopexy mesh (for prolapse). They all share a basic concept: a sheet or strip of synthetic material acts like a hammock, propping up organs or tissues that have shifted out of place. The mesh is surgically anchored to surrounding structures so it stays put while the body heals around it.
Nearly all commercial versions are made from polypropylene, a rigid, strong, nonabsorbable thermoplastic polymer. It became the go-to material because it is inexpensive, chemically resistant, and considered nontoxic in laboratory settings.1PubMed Central. Polypropylene Pelvic Mesh: What Went Wrong and What Will Be of the Future? The mesh is typically knitted from monofilament polypropylene threads into a porous sheet, and different products vary in weight, pore size, and stiffness. Those textile details turn out to matter quite a lot, because they influence how well the body tolerates the implant over time.
Why It Was Used So Widely
Stress urinary incontinence, meaning urine leaks during coughing, sneezing, or exercise, affects a large proportion of women, especially after childbirth or menopause. Pelvic organ prolapse, where the bladder, uterus, or rectum drops into the vaginal canal, is similarly common. Both conditions can significantly erode quality of life.
Before mesh, surgeons repaired these problems using the patient’s own tissue, stitching weakened ligaments and fascia back into place. Those “native tissue” repairs worked, but recurrence rates were a concern, especially for prolapse in the front vaginal wall. Mesh offered the promise of a stronger, more durable repair with a simpler operation and shorter recovery. Through the 2000s, dozens of mesh kits flooded the market, and the procedure became routine in gynecology and urology practices worldwide.
How the Body Reacts to the Implant
When polypropylene mesh is placed in the body, the immune system recognizes it as foreign. An immediate inflammatory response kicks in, which is supposed to lay the groundwork for tissue to grow into the mesh’s pores and integrate it into the surrounding structures.2PubMed. Polypropylene mesh and the host response In a best-case scenario, this process settles down within weeks and the mesh becomes part of the tissue.
In many patients, though, the inflammatory response does not resolve as planned. Studies of explanted mesh have found that immune cells called macrophages cluster around every mesh fiber and remain in a pro-inflammatory state long after implantation. Enzymes that break down surrounding tissue are also significantly elevated in the area around the mesh compared to healthy tissue.3PubMed Central. Host response to synthetic mesh in women with mesh complications This chronic, unresolved inflammation is a foreign body reaction, and when it becomes excessive, it can lead to mesh contraction, scarring, and poor tissue integration.4PubMed Central. The impact of steroid-impregnated polypropylene mesh on foreign body reaction in an experimental rat study These processes are at the root of many mesh complications.
Polypropylene mesh has also been associated with stiffness and deformation after implantation, meaning the material can change shape within the body, pulling on surrounding tissue and creating mechanical problems that compound the inflammatory ones.5PubMed Central. Significance of Textile Properties for the Design of a New Pelvic Implant to Treat Pelvic Organ Prolapse
The Range of Complications
The list of documented mesh complications is long and sobering. Pain, erosion of mesh through the vaginal wall, difficulty urinating, recurrent urinary tract infections, fistulae (abnormal connections between organs), organ perforation, bleeding, vaginal scarring, nerve and muscle problems, bowel complications, and even immune disorders have all been linked to pelvic mesh.6PubMed Central. Mesh complications: best practice in diagnosis and treatment
Pain is the complication that gets the most attention, and it takes several forms. It can be generalized pelvic or lower abdominal pain, pain during sex, or pain localized to specific muscles or nerves. The type of pain often depends on the surgical route: suprapubic pain is more common after retropubic sling placement, while groin pain is more common after the transobturator approach. In many cases, the exact cause is unclear, but the mesh itself may contribute through scarring, contraction, low-grade infection, nerve irritation, or muscle inflammation.7Continence. Complications associated with the use of mesh to treat female urinary incontinence and pelvic organ prolapse
Mesh erosion, sometimes called exposure or extrusion, occurs when the mesh wears through the vaginal lining. It can cause discharge, bleeding, and pain during intercourse. Mesh contraction, where the material shrinks and tightens over time, may also play an important role in delayed injury to the urinary tract, especially after anchored midurethral slings.8PubMed. Urethral mesh erosion after single-incision mid-urethral sling In rare cases, mesh can perforate into the bladder or bowel. Bladder perforation during the sling operation itself occurs in up to about four percent of midurethral sling procedures, though it is usually caught during surgery and corrected on the spot.9PubMed Central. Management of patients with mesh perforation into viscus following pelvic mesh surgery
How Surgical Approach Affects Risk
Not all mesh procedures carry the same risks. The two main categories are transvaginal procedures (mesh placed through the vagina) and abdominal procedures (mesh placed through the abdomen, as in sacrocolpopexy). In 2011, the FDA specifically flagged transvaginal mesh for prolapse repair, stating that serious complications with those products were “not rare.” Abdominal sacrocolpopexy, by comparison, may result in lower rates of mesh complications.10PubMed. Complications of vaginal mesh surgery
For incontinence slings, there are two common paths: the retropubic route (the sling passes behind the pubic bone) and the transobturator route (the sling passes through openings in the pelvic bone on either side). Research comparing the two has found that retropubic slings carry a higher likelihood of urinary retention and bleeding or hematoma, while transobturator slings are associated with slightly higher rates of urinary tract infection.11PubMed. Complications following retropubic versus transobturator midurethral synthetic sling placement In a study of women with recurrent incontinence, overall complication rates did not differ significantly between the two approaches, and both had long-term complication rates in the range of roughly one in five to one in seven patients.12PubMed Central. Transvaginal Retropubic Versus Transobturator Midurethral Sling in the Treatment of Recurrent Stress Urinary Incontinence
The Regulatory Crackdown
The FDA’s response to mesh complications unfolded over about a decade. In 2008, the agency issued its first public health notification about complications. In 2011, it warned that serious complications from transvaginal mesh for prolapse were not rare and questioned whether mesh offered any advantage over non-mesh repair for prolapse. By 2016, the FDA reclassified transvaginal prolapse mesh from moderate risk (class II) to high risk (class III), requiring manufacturers to submit premarket approval applications proving safety and effectiveness. When no manufacturer successfully did so, the FDA in April 2019 ordered the remaining products off the U.S. market.13BMJ. Transvaginal mesh: FDA orders remaining products off US market
Similar actions followed internationally. The UK, Canada, Australia, New Zealand, and France all restricted or removed transvaginal mesh products. However, in much of mainland Europe, Asia, and South America, these meshes remained available as a surgical option for prolapse correction.14PubMed Central. The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery Midurethral slings for incontinence were not included in the FDA’s ban and remain in use in the U.S. and elsewhere, though they are subject to greater scrutiny than before.
The Psychological Toll
Mesh complications are not just physical. Women who develop problems after mesh surgery report experiences that are psychologically traumatic, including severe anxiety and, in some cases, suicidal thoughts. Intimate relationships suffer as well, with reduced sexual function and diminished physical closeness stemming from pain and mesh-related dysfunction.15PubMed Central. When things go wrong: experiences of vaginal mesh complications
A large UK cohort study quantified some of this burden. Women with no prior history of mental health problems who underwent mesh surgery for incontinence had roughly two and a half times the rate of depression, anxiety, or self-harm compared to women who did not have mesh, and about twice the rate of sexual dysfunction. Opioid use was also significantly elevated. Women who had mesh for prolapse showed a similar pattern, though the increases were somewhat smaller.16PubMed Central. The Long-Term Impact of Vaginal Surgical Mesh Devices in UK Primary Care: A Cohort Study in the Clinical Practice Research Datalink A systematic review of qualitative studies described a common emotional landscape among affected women: frustration, anger, guilt, self-blame, depression, and in some cases, reliance on unhealthy coping strategies.17BMJ Open. Pain and other complications of pelvic mesh: a systematic review of qualitative studies and thematic synthesis of women’s accounts
Diagnosing Mesh Problems
Mesh complications can be tricky to pin down. Symptoms like pelvic pain, recurrent infections, and urinary difficulties overlap with many other conditions, and some problems do not appear until years after surgery. Imaging plays a central role in evaluation. Ultrasound is often the first step and is good at showing midurethral slings in the tissue between the urethra and vagina. MRI is better for visualizing mesh that extends deeper, such as the arms of a sling reaching into the space behind the pubic bone, mesh along the vaginal wall near the sacrospinous ligaments, and sacrocolpopexy mesh in the abdomen.18PubMed. Postoperative Imaging after Surgical Repair for Pelvic Floor Dysfunction Depending on the complaint, cystoscopy (a camera inside the bladder) may be needed to check for mesh erosion into the urinary tract, and CT or voiding studies can be used in specific cases.19PubMed Central. MR scan evaluation of pelvic organ prolapse mesh complications and agreement with intra-operative findings
What Mesh Removal Involves
For women with significant complications, partial or complete mesh removal is sometimes the only path forward. This is not a simple reversal. The mesh, by design, becomes embedded in surrounding tissue as the body heals around it. Removing it means dissecting the material out of living tissue, often near the bladder, urethra, and nerves. The surgery requires advanced expertise, and outcomes are mixed. Most patients who undergo vaginal mesh removal do get relief from their presenting symptoms, but results for pain, sexual function, continence, and prolapse can be unpredictable. Some women need multiple operations.20PubMed. Long-term Outcomes and Complications of Trans-vaginal Mesh Removal: A 14-year Experience
The unpredictability is a difficult reality. Removing mesh may solve pain but cause new incontinence, or resolve erosion but leave chronic discomfort. Women considering removal should seek out a surgeon with specific experience in mesh explant procedures, as the complexity of the operation is significantly higher than the original implantation.
Non-Mesh Alternatives
Given the controversy, many patients and surgeons now prefer approaches that avoid synthetic mesh altogether, at least for transvaginal prolapse repair.
Native tissue repair, where the surgeon uses the patient’s own ligaments and fascia to reconstruct support, is the most common mesh-free option for prolapse. In a study tracking patients for ten years after native tissue repair using uterosacral ligament suspension, anatomic recurrence was found in about one in five women, but only about six percent reported prolapse symptoms, and just two percent needed repeat surgery.21PubMed Central. Native‐tissue prolapse repair: Efficacy and adverse effects of uterosacral ligaments suspension at 10‐year follow up A study comparing native tissue repair to sacrocolpopexy (an abdominal mesh procedure) found that native tissue repair had a higher rate of surgical failure on examination, but actual retreatment rates were low in both groups and not significantly different.22Scientific Reports. Comparison of treatment outcomes for native tissue repair and sacrocolpopexy as apical suspension procedures at the time of hysterectomy for uterine prolapse Success rates of native tissue repair for apical prolapse also appear to hold up well across different age groups, with around three-quarters to more than four-fifths of patients reporting good outcomes at mid- to long-term follow-up.23PubMed Central. Impact of age on mid- to long-term outcomes of transvaginal native tissue repair for apical vaginal prolapse
For incontinence, autologous fascial slings, which use a strip of the patient’s own abdominal tissue as the sling material, have seen a resurgence. Although the procedure is technically more demanding and takes longer than synthetic sling placement, long-term success rates are high, and the risk of serious complications like mesh erosion, chronic pelvic pain, and painful intercourse is very low.24PubMed Central. Autologous Fascial Slings for Surgical Management of Stress Urinary Incontinence: A Come Back A meta-analysis found that autologous fascial slings delivered similar urinary continence results and complication rates to synthetic midurethral slings at medium- and long-term follow-up.25PubMed Central. Comparison of midurethral tape with autologous rectus fascial sling surgery for stress urinary incontinence: A systematic review and meta-analysis Direct comparisons using the transobturator route have reached the same conclusion: autologous grafts performed just as well as synthetic mesh.26PubMed Central. Comparison of Autologous Rectus Fascia and Synthetic Sling Methods of Transobturator Mid-Urethral Sling in Urinary Stress Incontinence
Other non-surgical options also exist. For mild incontinence, pelvic floor muscle training (Kegel exercises) and certain medications can provide meaningful improvement. For prolapse, a pessary, a silicone device inserted into the vagina to physically support dropped organs, can manage symptoms without any surgery at all. These conservative approaches are not permanent fixes, but they avoid surgical risk entirely.
Where Materials Research Is Headed
The mesh controversy has pushed researchers to look for better materials. One emerging direction is bioresorbable mesh, designed to provide temporary support while the body’s own tissue heals and then gradually dissolve, leaving no permanent foreign material behind. Biological meshes derived from animal or human tissue have also been tried, with the idea that they would provoke less of a foreign body reaction than synthetic plastic. The challenge has been durability: biological meshes tend to be weaker and break down too quickly, while purely synthetic meshes last but can cause chronic inflammation. Bioresorbable designs aim to split the difference, providing enough mechanical support during healing without leaving a permanent implant, though significant development work remains before these approaches are ready for widespread use.27PubMed Central. Emerging materials and technologies for advancing bioresorbable surgical meshes
Composite meshes that blend absorbable and permanent fibers represent another research avenue. One experimental design combined polypropylene with polylactic acid, a biodegradable material, in a knitted structure. The goal was a lighter, more porous mesh. The addition of the biodegradable component did not significantly strengthen the mesh, however, and it actually made it stiffer, a property associated with poor tissue response.28Textile Research Journal. Fabrication and evaluation of a warp knitted polypropylene/polylactic acid composite mesh for pelvic floor repair Findings like these illustrate why progress is slow: the pelvic floor is a demanding environment, constantly in motion and under mechanical stress, and getting the material properties right turns out to be extremely difficult. For now, the safest practical path for most patients is either a well-indicated midurethral sling (which remains on the market and, for many women, works without complications) or a mesh-free native tissue approach for prolapse.